HCKT(HCKT)
HCKT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $281M | $294M |
| Low | $277M | $293M |
| High | $284M | $295M |
| EBITDA Avg | $45M | $48M |
| Low | $45M | $47M |
| High | $46M | $48M |
| EBIT Avg | $42M | $44M |
| Low | $41M | $43M |
| High | $42M | $44M |
| Net Income Avg | $41M | $45M |
| Low | $41M | $45M |
| High | $41M | $46M |
| EPS Avg | $1.50 | $1.67 |
| Low | $1.49 | $1.66 |
| High | $1.51 | $1.67 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $72M | $72M | $70M | $71M | $75M | $74M |
| Low | $72M | $71M | $70M | $71M | $75M | $73M |
| High | $73M | $72M | $70M | $71M | $76M | $74M |
| EBITDA Avg | $12M | $12M | $11M | $11M | $12M | $12M |
| Low | $12M | $12M | $11M | $11M | $12M | $12M |
| High | $12M | $12M | $11M | $11M | $12M | $12M |
| EBIT Avg | $11M | $11M | $10M | $10M | $11M | $11M |
| Low | $11M | $11M | $10M | $10M | $11M | $11M |
| High | $11M | $11M | $10M | $11M | $11M | $11M |
| Net Income Avg | $10M | $11M | $9M | $10M | $11M | $12M |
| Low | $10M | $11M | $9M | $10M | $11M | $12M |
| High | $10M | $11M | $9M | $10M | $11M | $12M |
| EPS Avg | $0.40 | $0.42 | $0.35 | $0.40 | $0.43 | $0.46 |
| Low | $0.39 | $0.42 | $0.35 | $0.40 | $0.43 | $0.46 |
| High | $0.40 | $0.42 | $0.35 | $0.40 | $0.43 | $0.46 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |